Yuta Asano

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Machine Learning to Quantify In Situ Humoral Selection in Human Lupus Tubulointerstitial Inflammation”.

Machine Learning to Quantify In Situ Humoral Selection in Human Lupus Tubulointerstitial Inflammation

Frontiers in Immunology(2020)10.3389/fimmu.2020.593177

N/A

0DataRank · unranked

8 citations

Yuta Asano, Azam Mohsin, Carole Henry, Rebecca Abraham, Anthony Chang +4 more

In situ humoral selection in human lupus tubulointerstitial inflammation

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.29.178145

N/A

0DataRank · unranked

1 citations

Yuta Asano, Azam Mohsin, Carole Henry, Rebecca Abraham, Anthony Chang +4 more

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection

Nature Communications(2021)10.1038/s41467-021-24615-6

N/A

0DataRank · unranked

57 citations

Joe Daccache, Dharmendra Jain, Kichul Ko, Andrew J Kinloch, Margaret Veselits +10 more

In lupus nephritis, specific in situ inflammatory states are associated with refractory disease and progression to renal failure

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.03.458909

N/A

0DataRank · unranked

0 citations

Madeleine S. Durkee, Junting Ai, Margaret Veselits, Gabriel Casella, Yuta Asano +7 more

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

Journal of Clinical Investigation(2022)10.1172/jci155350

N/A

0DataRank · unranked

71 citations

Madeleine S. Durkee, Junting Ai, Margaret Veselits, Gabriel Casella, Yuta Asano +7 more

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence

Nature Communications(2025)10.1038/s41467-025-60394-0

N/A

0DataRank · unranked

9 citations

L. Martin, Daniel Egan, Merav Bar, Sinéad Kinsella, Kelly G. Paulson +19 more